Maria E. Balasis - Concepedia

Author

Maria E. Balasis

Moffitt Cancer Center ORCID

Also Known As

Chia-Feng Tsai, M Balasis, M. Balasis, M.E. Balasis, Maria Balasis, Maria E Balasis, Maria E. Balasis

224

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Moffitt Cancer Center University of South Florida Dana-Farber Cancer Institute Sidney Kimmel Comprehensive Cancer Center Institut Gustave Roussy

About

Maria E. Balasis is an author at Moffitt Cancer Center specializing in medicine, medicinal chemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	733
2	Biomolecular Engineering	2	2	241
3	Health Sciences	1	1	119
4	Natural Sciences	1	1	13
5	Biochemistry	1	1	13

Maria E. Balasis

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90 Purva Bali, Michael Pranpat, James E. Bradner, Journal of Biological Chemistry	2005	746
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study Nancy Gillis, Markus Ball, Qing Zhang, The Lancet Oncology Hematological MalignancyOncologyBone Marrow FailureElderly PatientsMalignant Blood Disorder	2016	307
Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin Fei Guo, Kathy Rocha, Purva Bali, Cancer Research ApoptosisImmunologyCell DeathIncrease Antileukemia ActivityPharmaceutical Chemistry	2005	214
Activity of Suberoylanilide Hydroxamic Acid Against Human Breast Cancer Cells with Amplification of Her-2 Purva Bali, Michael Pranpat, Ramona F. Swaby, Clinical Cancer Research	2005	186
Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl–expressing human leukemia cells Warren Fiskus, Michael Pranpat, Purva Bali, Blood	2006	146
Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays Catherine C. Coombs, Nancy Gillis, Xianming Tan, Clinical Cancer Research Solid Tumor PatientsPathologyTumor BiologyMyeloid NeoplasiaHematological Malignancy	2018	119
Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells Warren Fiskus, Michael Pranpat, Maria E. Balasis, Molecular Cancer Therapeutics	2006	112
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML Akihide Yoshimi, Maria E. Balasis, Alexis Vedder, Blood	2017	101
Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells Warren Fiskus, Michael Pranpat, Maria E. Balasis, Clinical Cancer Research	2006	100
A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML) Eric Padron, Amy E. DeZern, Marcio Andrade‐Campos, Clinical Cancer Research	2016	95

Page 1